Infect Chemother.  2017 Jun;49(2):123-129. 10.3947/ic.2017.49.2.123.

Tuberculous Meningitis-Mimicking Varicella-Zoster Meningitis

Affiliations
  • 1Division of Infectious Diseases, Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University School of Medicine, Changwon, Korea.
  • 2Division of Infectious Diseases, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, Korea.
  • 3Division of Infectious Diseases, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
  • 4Division of Infectious Diseases, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.
  • 5Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. kimsunghanmd@hotmail.com
  • 6Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Abstract

BACKGROUND
Varicella-zoster virus (VZV) is one of the most common etiologies of aseptic meningitis. The severest manifestation of VZV meningitis is occasionally confused with tuberculous meningitis (TBM). Thus, we investigated the clinical manifestations of VZV meningitis as compared with those of TBM.
MATERIALS AND METHODS
All adult patients who were diagnosed with VZV meningitis or TBM were enrolled at a tertiary hospital in Seoul, South Korea, during an 8-year period. The clinical characteristics and cerebrospinal fluid (CSF) profile of patients were analyzed.
RESULTS
Seventy-nine patients with VZV meningitis and 24 patients with TBM were enrolled in this study. Of the 79 patients with VZV meningitis, 63 (80%) did not received empirical anti-tuberculous therapy (Group 1) and the remaining 16 (20%) received empirical anti-tuberculous therapy (Group 2), compared with 24 patients with TBM (Group 3). Altered mental status, intensive care unit (ICU) admission, neurologic sequelae, CSF protein levels, and CSF adenosine deaminase levels revealed a trend of being higher in Group 3 than Group 2, which was higher than Group 1. However, the CSF/serum glucose ratio was significantly lower in Group 3 than in Group 1 or Group 2.
CONCLUSION
About one fifth of VZV meningitis cases presented as severe manifestations, mimicking TBM. The CSF/serum glucose ratio might be useful to differentiate VZV meningitis from TBM until definite diagnostic tests are available. Physicians should keep in mind that a differential diagnosis between severe VZV meningitis and TBM is needed.

Keyword

Herpesvirus 3, Human; Tuberculosis, Meningeal

MeSH Terms

Adenosine Deaminase
Adult
Cerebrospinal Fluid
Diagnosis, Differential
Diagnostic Tests, Routine
Glucose
Herpesvirus 3, Human
Humans
Intensive Care Units
Korea
Meningitis*
Meningitis, Aseptic
Seoul
Tertiary Care Centers
Tuberculosis, Meningeal
Adenosine Deaminase
Glucose

Reference

1. Grahn A, Studahl M. Varicella-zoster virus infections of the central nervous system – prognosis, diagnostics and treatment. J Infect. 2015; 71:281–293.
Article
2. Lee JE, Lee S, Kim KH, Jang HR, Park YJ, Kang JS, Han SY, Lee SH. A case of transverse myelitis caused by varicella zoster virus in an immunocompetent older patient. Infect Chemother. 2016; 48:334–337.
Article
3. Ihekwaba UK, Kudesia G, McKendrick MW. Clinical features of viral meningitis in adults: significant differences in cerebrospinal fluid findings among herpes simplex virus, varicella zoster virus, and enterovirus infections. Clin Infect Dis. 2008; 47:783–789.
Article
4. Glaser CA, Gilliam S, Schnurr D, Forghani B, Honarmand S, Khetsuriani N, Fischer M, Cossen CK, Anderson LJ. California Encephalitis Project, 1998-2000. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. Clin Infect Dis. 2003; 36:731–742.
Article
5. Persson A, Bergström T, Lindh M, Namvar L, Studahl M. Varicella-zoster virus CNS disease--viral load, clinical manifestations and sequels. J Clin Virol. 2009; 46:249–253.
Article
6. Kim SH, Cho OH, Park SJ, Lee EM, Kim MN, Lee SO, Choi SH, Kim YS, Woo JH, Lee SA, Kang JK. Rapid diagnosis of tuberculous meningitis by T cell-based assays on peripheral blood and cerebrospinal fluid mononuclear cells. Clin Infect Dis. 2010; 50:1349–1358.
Article
7. Lee YM, Kim SM, Park SJ, Park KH, Lee SO, Choi SH, Kim YS, Woo JH, Kim SH. Indeterminate T-SPOT.TB test results in patients with suspected extrapulmonary tuberculosis in routine clinical practice. Infect Chemother. 2013; 45:44–50.
Article
8. Tuon FF, Higashino HR, Lopes MI, Litvoc MN, Atomiya AN, Antonangelo L, Leite OM. Adenosine deaminase and tuberculous meningitis--a systematic review with meta-analysis. Scand J Infect Dis. 2010; 42:198–207.
Article
9. Park KH, Lee MS, Kim SM, Park SJ, Chong YP, Lee SO, Choi SH, Kim YS, Woo JH, Kang JK, Lee SA, Kim SH. Diagnostic usefulness of T-cell based assays for tuberculous meningitis in HIV-uninfected patients. J Infect. 2016; 72:486–497.
Article
10. Thwaites G, Chau TT, Mai NT, Drobniewski F, McAdam K, Farrar J. Tuberculous meningitis. J Neurol Neurosurg Psychiatry. 2000; 68:289–299.
11. Thwaites GE, Caws M, Chau TT, Dung NT, Campbell JI, Phu NH, Hien TT, White NJ, Farrar JJ. Comparison of conventional bacteriology with nucleic acid amplification (amplified mycobacterium direct test) for diagnosis of tuberculous meningitis before and after inception of antituberculosis chemotherapy. J Clin Microbiol. 2004; 42:996–1002.
Article
12. Shankar P, Manjunath N, Shriniwas , Mohan KK, Prasad K, Behari M, Ahuja GK. Rapid diagnosis of tuberculous meningitis by polymerase chain reaction. Lancet. 1991; 337:5–7.
Article
13. Miörner H, Sjöbring U, Nayak P, Chandramuki A. Diagnosis of tuberculous meningitis: a comparative analysis of 3 immunoassays, an immune complex assay and the polymerase chain reaction. Tuber Lung Dis. 1995; 76:381–386.
Article
14. Bonington A, Strang JI, Klapper PE, Hood SV, Rubombora W, Penny M, Willers R, Wilkins EG. Use of Roche AMPLICOR Mycobacterium tuberculosis PCR in early diagnosis of tuberculous meningitis. J Clin Microbiol. 1998; 36:1251–1254.
Article
15. Dora JM, Geib G, Chakr R, Paris F, Mombach AB, Lutz L, Souza CF, Goldani LZ. Polymerase chain reaction as a useful and simple tool for rapid diagnosis of tuberculous meningitis in a Brazilian tertiary care hospital. Braz J Infect Dis. 2008; 12:245–247.
Article
16. Huang HJ, Xiang DR, Sheng JF, Li J, Pan XP, Yu HY, Sheng GP, Li LJ. rpoB nested PCR and sequencing for the early diagnosis of tuberculous meningitis and rifampicin resistance. Int J Tuberc Lung Dis. 2009; 13:749–754.
17. Lakeman FD, Whitley RJ. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis. 1995; 171:857–863.
Article
18. Boivin G. Diagnosis of herpesvirus infections of the central nervous system. Herpes. 2004; 11:Suppl 2. 48A–56A.
19. Xu HB, Jiang RH, Li L, Sha W, Xiao HP. Diagnostic value of adenosine deaminase in cerebrospinal fluid for tuberculous meningitis: a meta-analysis. Int J Tuberc Lung Dis. 2010; 14:1382–1387.
20. Choi SH, Kim YS, Bae IG, Chung JW, Lee MS, Kang JM, Ryu J, Woo JH. The possible role of cerebrospinal fluid adenosine deaminase activity in the diagnosis of tuberculous meningitis in adults. Clin Neurol Neurosurg. 2002; 104:10–15.
Article
21. Moghtaderi A, Niazi A, Alavi-Naini R, Yaghoobi S, Narouie B. Comparative analysis of cerebrospinal fluid adenosine deaminase in tuberculous and non-tuberculous meningitis. Clin Neurol Neurosurg. 2010; 112:459–462.
Article
22. Rana SV, Chacko F, Lal V, Arora SK, Parbhakar S, Sharma SK, Singh K. To compare CSF adenosine deaminase levels and CSF-PCR for tuberculous meningitis. Clin Neurol Neurosurg. 2010; 112:424–430.
Article
Full Text Links
  • IC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr